Trial demonstrated that PP353 delivers clinically meaningful and durable reduction in pain and disability in patients with chronic Low Back Pain and Modic Type 1 changes PP353 has the potential to ...

August 20, 2024 — Among patients undergoing lumbar spinal fusion, the presence of Modic changes is associated with differences in microbial diversity and metabolites in the lumbar cartilaginous ...

Chronic lower back pain is one of the top complaints that sends Americans to their doctors — and it’s a leading cause of missed workdays and disability claims. While slipped discs, arthritis and ...

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Persica Pharmaceuticals will advance its antibiotic-based drug to registrational studies after a Phase Ib study found that the therapy alleviated lower back pain in patients. The UK-based biotech said ...

Persica Pharmaceuticals completes recruitment into Modic Trial assessing efficacy of PP353, to treat chronic lower back pain London, UK, 07 March 2024 – Persica Pharmaceuticals Ltd, a privately held, ...

Rest no better than exercise for back pain No differences were found between those who exercised or those who rested on any outcome measure, including pain, disability, general health and global ...